• Loading stock data…

Peptilogics Receives Award from the Cystic Fibrosis Foundation to Investigate PLG0301 and PLG0206 as Potential Dual-Acting Treatments for Lung Infections Associated with Cystic Fibrosis

[#item_full_content]

Print Friendly, PDF & Email
Spread the word